The latest NAV of UTI Healthcare Fund – Direct Plan is ₹376.49 as of 2026-07-28.
The returns of UTI Healthcare Fund – Direct Plan are 12.55% for 1 year, 90.97% for 3 years and 109.59% for 5 years, as per the latest available data. Investors should compare these returns with the category average and benchmark before making a decision.
The investment objective of UTI Healthcare Fund – Direct Plan : An open-ended fund which exclusively invests in the equities of the Pharma & Healthcare sector companies. This fund is one of the growth sector funds aiming to invest in companies engaged in business of manufacturing and marketing of bulk drug, formulations and healthcare products and services.
UTI Healthcare Fund – Direct Plan has a Very High risk rating as per the fund’s riskometer. Investors should check whether this risk level matches their investment horizon, financial goals and ability to handle market volatility.
The AUM, or Assets Under Management, of UTI Healthcare Fund – Direct Plan is ₹1307.98 crore. AUM indicates the total money managed under the scheme. Higher AUM may reflect investor confidence, but fund performance, consistency and portfolio quality should also be reviewed.
The expense ratio of UTI Healthcare Fund – Direct Plan is 1.31. This is the annual fee charged by the fund house for managing the scheme. A lower expense ratio can help improve net returns over the long term, but it should not be the only factor used to judge a fund.